✦ LIBER ✦

Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab

✍ Scribed by Bittenbring, J. T.; Neumann, F.; Altmann, B.; Achenbach, M.; Reichrath, J.; Ziepert, M.; Geisel, J.; Regitz, E.; Held, G.; Pfreundschuh, M.

Book ID: 127295913
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 442 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2013.53.4537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concomitant statin use does not impair t

Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

✍ Panagiotis Samaras; Helen Heider; Sarah R. Haile; Ulf Petrausch; Niklaus G. Scha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 154 KB

The impact of Fc- receptor polymorphisms

The impact of Fc- receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab

✍ Ahlgrimm, M.; Pfreundschuh, M.; Kreuz, M.; Regitz, E.; Preuss, K.-D.; Bittenbrin 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 376 KB

Lack of prognostic significance of the g

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

✍ Ivana Ilić; Zdravko Mitrović; Igor Aurer; Sandra Bašić-Kinda; Ivo Radman; Radmil 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 268 KB

Matched-pair analysis comparing the outc

Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy

✍ Ho-Young Yhim; Jin Seok Kim; Hye Jin Kang; Seok Jin Kim; Won Seog Kim; Chul Won 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 997 KB

Disease staging with positron emission t

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation

✍ Amin M. Alousi; Rima M. Saliba; Grace-Julia Okoroji; Homer A. Macapinlac; Chitra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Mutational Profile and Prognostic Signif

Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study

✍ Xu-Monette, Zijun Y.; Wu, Lin; Visco, Carlo; Tai, Yu Chuan; Tzankov, Alexander; 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 64 KB